相关实验视频
Updated: Jun 26, 2026
08:15
Polymeric Microneedle Array Fabrication by Photolithography
Published on: November 17, 2015
12.3K
DNA四面体功能化微针阻断IL-6促进皮肤伤口愈合
Yuqing Wang1,2,3, Jiale Liang1,2,3, Ye Chen1,2,3
1State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, P. R. China.
ACS applied materials & interfaces
|July 16, 2025
概括
新的微针敷料通过抑制INTERLEUKIN-6 (IL-6) 和促进愈合,有效地治疗炎症性伤口. 这种基于DNA的方法为治疗伤口炎症的抗体疗法提供了一个有希望的替代方案.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 伤口治愈研究研究 伤口治愈研究
背景情况:
- 过度的IN-6 (IL-6) 分泌会阻碍炎症性伤口愈合.
- 基于抗体的IL-6中和面临着免疫性和降低疗效等挑战.
- 与抗体相比,aptamers (Ap) 具有更高的特异性和抗炎性质.
研究的目的:
- 开发一种新的药物输送系统,以增强抗炎和伤口愈合能力.
- 为了利用四面体框架核酸 (tFNAs) 作为一个稳定的平台,为aptamer交付.
- 为了创建一个水凝微针 (MN) 敷料,结合tFNAs与IL-6体 (tFNAs Ap) 功能化,用于局部治疗.
主要方法:
- 修改IL-6的体对tFNAs (tFNAs Ap) 的修改.
- 在水凝微针中嵌入tFNAs Ap (tFNAs Ap MN).
- 在动物模型中评估微针特性 (机械强度,胀,生物相容性) 和体内伤口愈合疗效.
主要成果:
- 这种tFNAs Ap MN表现出极好的机械强度,膨胀能力和生物相容性.
- 微针通过抑制IL-6和TNF-α显示出显著的抗炎作用.
- 在动物模型中,tFNAs Ap MN促进了角质细胞的增殖和迁移,加速了全厚皮肤伤口的愈合.
结论:
- 在tFNA平台上与DNA吸附体功能化的水凝微针显示出治疗炎症性伤口的巨大潜力.
- 这种方法有效地抑制了过量的IL-6,减少了炎症,并加速了伤口愈合.
- 开发的DNA材料功能化的微针代表了一个有前途的治疗策略,在炎症和伤口管理方面具有潜在的临床价值.
相关概念视频
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:29Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...